Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference Feb 27, 2026 04:00PM
Arcutis to Present at Upcoming Investor Conferences Oct 27, 2025 04:00PM
Arcutis to Present at the TD Cowen 45th Annual Health Care Conference Feb 18, 2025 04:35PM
TD Cowen Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT) Aug 15, 2024 09:21AM
TD Cowen Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT) Jul 10, 2024 07:35AM
View Older Stories

Mar 4, 2024 04:00PM Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Feb 29, 2024 05:00PM Arcutis to Present at the TD Cowen 44th Annual Health Care Conference
Feb 28, 2024 11:32PM Arcutis Biotherapeutics (ARQT) Announces Pricing of $150 Mln Public Offering
Feb 28, 2024 11:30PM Arcutis Announces Pricing of $150 Million Public Offering
Feb 28, 2024 04:10PM Arcutis Biotherapeutics (ARQT) Announces Proposed $150M Share Offering
Feb 28, 2024 04:10PM Arcutis Announces Proposed Public Offering
Oct 20, 2023 05:06AM Arcutis Biotherapeutics (ARQT) Prices $100M Offering at $2.50/sh
Oct 19, 2023 11:45PM Arcutis Announces Pricing of $100 Million Public Offering
Oct 19, 2023 04:05PM Arcutis Biotherapeutics (ARQT) Announces Proposed $100M Share Offering
Oct 19, 2023 04:04PM Arcutis Announces Proposed Public Offering
Feb 8, 2023 08:00AM Arcutis to Report Fourth Quarter 2022 Financial Results and Participate in Upcoming Investor Conference
Feb 8, 2023 08:00AM Arcutis to Report Fourth Quarter 2022 Financial Results and Participate in Upcoming Investor Conference
Aug 3, 2022 05:45AM Arcutis Biotherapeutics (ARQT) Prices 7.5M Share Offering at $20/sh, Above Yesterday's $19.50 Closing Price
Aug 2, 2022 09:26PM Arcutis Biotherapeutics Announces Pricing of Public Offering of Common Stock
Aug 2, 2022 09:26PM Arcutis Biotherapeutics Announces Pricing of Public Offering of Common Stock
Aug 2, 2022 04:02PM Arcutis Biotherapeutics Inc. (ARQT) Announces Proposed $150M Stock Offering
Aug 2, 2022 04:02PM Arcutis Biotherapeutics Announces Proposed Public Offering of Common Stock
Aug 2, 2022 04:02PM Arcutis Biotherapeutics Announces Proposed Public Offering of Common Stock
Mar 2, 2022 05:30AM Arcutis to Present at Upcoming Investor Conference
Mar 2, 2022 05:30AM Arcutis to Present at Upcoming Investor Conference
Feb 25, 2021 05:15PM Arcutis to Present at the Cowen 41st Annual Health Care Conference
Feb 25, 2021 05:15PM Arcutis to Present at the Cowen 41st Annual Health Care Conference
Feb 16, 2021 09:00AM Arcutis Biotherapeutics Announces Closing of Underwriters’ Over-Allotment Option in Connection with Public Offering of Common Stock
Feb 3, 2021 05:41AM Arcutis Biotherapeutics Inc. (ARQT) Prices 5.5M Share Upsized Common Offering at $35/Sh
Feb 2, 2021 08:03PM Arcutis Biotherapeutics Announces Pricing of Upsized Public Offering of Common Stock
Feb 1, 2021 04:09PM Arcutis Biotherapeutics Inc. (ARQT) to Offer $150M in Common Stock
Feb 1, 2021 04:09PM Arcutis Biotherapeutics Announces Proposed Public Offering of Common Stock
Feb 1, 2021 09:46AM Arcutis Biotherapeutics Inc. (ARQT) PT Raised to 'Street High' $80 at Cowen
Oct 6, 2020 04:05PM Arcutis Biotherapeutics Announces Closing of Public Offering and Concurrent Private Placement of Common Stock
Oct 2, 2020 06:11AM Arcutis Biotherapeutics Inc. (ARQT) Prices 4M Share Common Offering and Concurrent Private Placement
Oct 1, 2020 10:47PM Arcutis Biotherapeutics Announces Pricing of Public Offering and Concurrent Private Placement of Common Stock
Sep 29, 2020 04:52PM Arcutis Bio (ARQT) Announces 4M Share Proposed Public Offering and Concurrent $35M Private Placement of Common Stock
Sep 29, 2020 04:51PM Arcutis Biotherapeutics Announces Proposed Public Offering and Concurrent Private Placement of Common Stock
Feb 25, 2020 05:45AM Cowen Starts Arcutis Biotherapeutics Inc. (ARQT) at Outperform
Feb 19, 2020 08:30AM Arcutis to Present at the Cowen 40th Annual Health Care Conference
Feb 19, 2020 08:30AM Arcutis to Present at the Cowen 40th Annual Health Care Conference
Feb 4, 2020 04:05PM Arcutis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Feb 4, 2020 04:05PM Arcutis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Feb 4, 2020 04:05PM Arcutis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 31, 2020 11:38AM Arcutis Biotherapeutics (ARQT) IPO Opens at 36% Higher
View Older Stories